XML 45 R33.htm IDEA: XBRL DOCUMENT v3.24.1.u1
SEGMENT REPORTING (Tables)
12 Months Ended
Dec. 31, 2023
Segment Reporting [Abstract]  
SCHEDULE OF SEGMENT REPORTING

Information concerning the operations of the Company’s reportable segments is as follows:

 

  

Year Ended

December 31, 2023

(000’s)

  

Year Ended

December 31, 2022

(000’s)

 
Revenues (from external customers)          
BioSig  $18   $286 
ViralClear   -    - 
BioSig AI Sciences   -    - 
Revenues  $18   $286 

 

  

Year Ended

December 31, 2023

(000’s)

  

Year Ended

December 31, 2022

(000’s)

 
Operating Expenses:          
BioSig  $29,238   $26,819 
ViralClear   (1,498)   672 
BioSig AI Sciences   745    3 
Operating Expenses  $28,530   $27,494 

 

  

Year Ended

December 31, 2023

(000’s)

  

Year Ended

December 31, 2022

(000’s)

 
(Loss) Income from Operations          
BioSig  $(29,265)  $(26,590)
ViralClear   1,498    (672)
BioSig AI Sciences   (745)   (3)
(Loss) Income from Operations  $(28,512)  $(27,265)

 

  

December 31, 2023

(000’s)

  

December 31, 2022

(000’s)

 
Total Assets          
BioSig  $485   $4,051 
ViralClear   -    49 
BioSig AI Sciences   1,313    10 
Total Assets  $1,798   $4,110